{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:24:20Z","timestamp":1782516260616,"version":"3.54.5"},"reference-count":88,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Spanish Ministerio de Economia y Competitividad","award":["SAF2014-59716-R"],"award-info":[{"award-number":["SAF2014-59716-R"]}]},{"name":"Spanish Ministerio de Economia y Competitividad","award":["BIO2014-56930-P"],"award-info":[{"award-number":["BIO2014-56930-P"]}]},{"name":"European Community\u2019s Seventh Framework Programme FP7","award":["HEALTH-F2-2011-256986, PANACREAS"],"award-info":[{"award-number":["HEALTH-F2-2011-256986, PANACREAS"]}]},{"name":"Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en C\u00e1ncer, Instituto de Salud Carlos III","award":["RD12\/0036\/0065"],"award-info":[{"award-number":["RD12\/0036\/0065"]}]},{"name":"The Royal Society-CSIC","award":["2004GB0032"],"award-info":[{"award-number":["2004GB0032"]}]},{"name":"Ram\u00f3n y Cajal Program from the Spanish Ministerio de Ciencia e Innovaci\u00f3n"},{"name":"Formaci\u00f3n de Profesorado Universitario predoctoral fellowship from the Spanish Ministerio de Ciencia e Innovaci\u00f3n"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0005805","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T17:35:30Z","timestamp":1503423330000},"page":"e0005805","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine"],"prefix":"10.1371","volume":"11","author":[{"given":"Janny A.","family":"Villa-Pulgar\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Gajate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Botet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Justies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n E.","family":"Varela-M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Cuesta-Marb\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0050-4693","authenticated-orcid":true,"given":"Ingrid","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Modolell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Revuelta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4939-2434","authenticated-orcid":true,"given":"Faustino","family":"Mollinedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"HW Murray","year":"2005","journal-title":"Lancet"},{"key":"ref2","first-page":"1","article-title":"Control of the leishmaniases","volume":"949","year":"2010","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"34528","DOI":"10.1074\/jbc.M110.125302","article-title":"Selective fusion of azurophilic granules with <italic>Leishmania<\/italic>-containing phagosomes in human neutrophils","volume":"285","author":"F Mollinedo","year":"2010","journal-title":"J Biol Chem"},{"issue":"Pt 18","key":"ref5","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1242\/jcs.112.18.2993","article-title":"<italic>Leishmania<\/italic> species: models of intracellular parasitism","volume":"112","author":"J Alexander","year":"1999","journal-title":"J Cell Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/1389200023337225","article-title":"Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH<sub>3<\/sub> (Edelfosine), a proapoptotic agent in tumor cells","volume":"3","author":"C Gajate","year":"2002","journal-title":"Curr Drug Metab"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1517\/13543776.17.4.385","article-title":"Antitumor ether lipids: proapoptotic agents with multiple therapeutic indications","volume":"17","author":"F Mollinedo","year":"2007","journal-title":"Expert Opin Ther Patents"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2174\/1871520614999140313160011","article-title":"Editorial: Antitumor alkylphospholipid analogs: a promising and growing family of synthetic cell membrane-targeting molecules for cancer treatment","volume":"14","author":"F Mollinedo","year":"2014","journal-title":"Anticancer Agents Med Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2001.19.21.4150","article-title":"Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer","volume":"19","author":"R Leonard","year":"2001","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"TP Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1128\/AAC.48.8.3010-3015.2004","article-title":"Possible mechanism of miltefosine-mediated death of <italic>Leishmania donovani<\/italic>","volume":"48","author":"NK Verma","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.48.3.852-859.2004","article-title":"Miltefosine induces apoptosis-like death in <italic>Leishmania donovani<\/italic> promastigotes","volume":"48","author":"C Paris","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(00)00278-4","article-title":"Ether-lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether-lipid analogues in <italic>Leishmania<\/italic>","volume":"111","author":"H Lux","year":"2000","journal-title":"Mol Biochem Parasitol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1128\/AAC.01332-13","article-title":"Miltefosine increases lipid and protein dynamics in <italic>Leishmania amazonensis<\/italic> membranes at concentrations similar to those needed for cytotoxicity activity","volume":"58","author":"RA Moreira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","first-page":"1320","article-title":"Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH<sub>3<\/sub> (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X<sub>L<\/sub>","volume":"57","author":"F Mollinedo","year":"1997","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/(SICI)1097-0215(20000415)86:2<208::AID-IJC10>3.0.CO;2-E","article-title":"Involvement of mitochondria and caspase-3 in ET-18-OCH<sub>3<\/sub>-induced apoptosis of human leukemic cells","volume":"86","author":"C Gajate","year":"2000","journal-title":"Int J Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.20040213","article-title":"Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis","volume":"200","author":"C Gajate","year":"2004","journal-title":"J Exp Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood-2006-04-016824","article-title":"Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts","volume":"109","author":"C Gajate","year":"2007","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/onc.2010.131","article-title":"Lipid raft-targeted therapy in multiple myeloma","volume":"29","author":"F Mollinedo","year":"2010","journal-title":"Oncogene"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/1871520614666140309222259","article-title":"Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine","volume":"14","author":"C Gajate","year":"2014","journal-title":"Anticancer Agents Med Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2217\/fon.10.34","article-title":"Lipid rafts and clusters of apoptotic signaling molecule-enriched rafts in cancer therapy","volume":"6","author":"F Mollinedo","year":"2010","journal-title":"Future Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s10495-015-1104-6","article-title":"Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling","volume":"20","author":"C Gajate","year":"2015","journal-title":"Apoptosis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1189\/jlb.2MR0215-055R","article-title":"Lipid raft-mediated Fas\/CD95 apoptotic signaling in leukemic cells and normal leukocytes and therapeutic implications","volume":"98","author":"C Gajate","year":"2015","journal-title":"J Leukoc Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2958.2004.04208.x","article-title":"Rafts and sphingolipid biosynthesis in the kinetoplastid parasitic protozoa","volume":"53","author":"PW Denny","year":"2004","journal-title":"Mol Microbiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.exppara.2009.02.012","article-title":"<italic>Leishmania<\/italic> (<italic>Viannia<\/italic>) <italic>panamensis<\/italic>: an in vitro assay using the expression of GFP for screening of antileishmanial drug","volume":"122","author":"MR Varela","year":"2009","journal-title":"Exp Parasitol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e1612","DOI":"10.1371\/journal.pntd.0001612","article-title":"<italic>In vitro<\/italic> and <italic>in vivo<\/italic> efficacy of ether lipid edelfosine against <italic>Leishmania<\/italic> spp. and SbV-resistant parasites","volume":"6","author":"RE Varela-M","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.exppara.2010.05.016","article-title":"<italic>Leishmania tarentolae<\/italic>: utility as an <italic>in vitro<\/italic> model for screening of antileishmanial agents","volume":"126","author":"VM Taylor","year":"2010","journal-title":"Exp Parasitol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature00935","article-title":"Functional profiling of the <italic>Saccharomyces cerevisiae<\/italic> genome","volume":"418","author":"G Giaever","year":"2002","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10495-006-4570-z","article-title":"Heat-induced programmed cell death in <italic>Leishmania infantum<\/italic> is reverted by Bcl-X<sub>L<\/sub> expression","volume":"11","author":"JF Alzate","year":"2006","journal-title":"Apoptosis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood-2004-07-2521","article-title":"Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity","volume":"105","author":"M Munder","year":"2005","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1124\/jpet.108.148254","article-title":"Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis","volume":"329","author":"F Mollinedo","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-5793(96)01451-2","article-title":"Oxidation of N(G)-hydroxyl-L-arginine to nitric oxide mediated by respiratory burst: an alternative pathway to NO synthesis","volume":"401","author":"M Modolell","year":"1997","journal-title":"FEBS Lett"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0003-2697(88)90354-5","article-title":"Clinical and biochemical applications of luciferases and luciferins","volume":"175","author":"LJ Kricka","year":"1988","journal-title":"Anal Biochem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7705\/biomedica.v24i4.1289","article-title":"Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application","volume":"24","author":"HH Henao","year":"2004","journal-title":"Biomedica"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z","article-title":"Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis","volume":"85","author":"C Gajate","year":"2000","journal-title":"Int J Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e5044","DOI":"10.1371\/journal.pone.0005044","article-title":"Involvement of raft aggregates enriched in Fas\/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells","volume":"4","author":"C Gajate","year":"2009","journal-title":"PLoS ONE"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1038\/cddis.2011.41","article-title":"Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria","volume":"2","author":"F Mollinedo","year":"2011","journal-title":"Cell Death Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bbrc.2009.01.147","article-title":"Lipid raft connection between extrinsic and intrinsic apoptotic pathways","volume":"380","author":"C Gajate","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1182\/blood.V98.13.3860","article-title":"The antitumor ether lipid ET-18-OCH<sub>3<\/sub> induces apoptosis through translocation and capping of Fas\/CD95 into membrane rafts in human leukemic cells","volume":"98","author":"C Gajate","year":"2001","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/ac950914h","article-title":"Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels","volume":"68","author":"A Shevchenko","year":"1996","journal-title":"Anal Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","article-title":"Probability-based protein identification by searching sequence databases using mass spectrometry data","volume":"20","author":"DN Perkins","year":"1999","journal-title":"Electrophoresis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/1078-0432.CCR-08-1654","article-title":"Antitumor alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice","volume":"15","author":"A Estella-Hermoso de Mendoza","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1158\/1078-0432.CCR-09-2456","article-title":"<italic>In vitro<\/italic> and <italic>in vivo<\/italic> selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts","volume":"16","author":"F Mollinedo","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/mol.53.4.602","article-title":"Involvement of c-<italic>Jun<\/italic> NH<sub>2<\/sub>-terminal kinase activation and c-<italic>Jun<\/italic> in the induction of apoptosis by the ether phospholipid 1-<italic>O<\/italic>-octadecyl-2-<italic>O<\/italic>-methyl-<italic>rac<\/italic>-glycero-3-phosphocholine","volume":"53","author":"C Gajate","year":"1998","journal-title":"Mol Pharmacol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"14833","DOI":"10.1074\/jbc.M511251200","article-title":"Differential targets and subcellular localization of antitumor alkyl-lysophospholipid in leukemic <italic>versus<\/italic> solid tumor cells","volume":"281","author":"T Nieto-Miguel","year":"2006","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1038\/onc.2011.446","article-title":"Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum","volume":"31","author":"C Gajate","year":"2012","journal-title":"Oncogene"},{"key":"ref47","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1902s28","article-title":"Animal models for the analysis of immune responses to leishmaniasis","author":"DL Sacks","year":"2001","journal-title":"Curr Protoc Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1021\/jm049808a","article-title":"Fluorescent phenylpolyene analogues of the ether phospholipid edelfosine for the selective labeling of cancer cells","volume":"47","author":"E Quesada","year":"2004","journal-title":"J Med Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1021\/jm070595+","article-title":"Synthesis and biological evaluation of fluorescent leishmanicidal analogues of hexadecylphosphocholine (miltefosine) as probes of antiparasite mechanisms","volume":"50","author":"JM Saugar","year":"2007","journal-title":"J Med Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1023\/A:1006810523586","article-title":"Mitochondrial function as a determinant of recovery or death in cell response to injury","volume":"184","author":"F Di Lisa","year":"1998","journal-title":"Mol Cell Biochem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.pharmtox.40.1.353","article-title":"Mitochondrial targets of drug toxicity","volume":"40","author":"KB Wallace","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1073\/pnas.82.6.1589","article-title":"Mechanism of inhibition of mitochondrial adenosine triphosphatase by dicyclohexylcarbodiimide and oligomycin: relationship to ATP synthesis","volume":"82","author":"HS Penefsky","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0022-2275(20)34940-3","article-title":"Use of cyclodextrins for manipulating cellular cholesterol content","volume":"38","author":"AE Christian","year":"1997","journal-title":"J Lipid Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1038\/bcj.2013.15","article-title":"Lipid raft-mediated Akt signaling as a therapeutic target in mantle cell lymphoma","volume":"3","author":"M Reis-Sobreiro","year":"2013","journal-title":"Blood Cancer J"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1021\/bi00438a017","article-title":"Thermodynamics of intersubunit interactions in cholera toxin upon binding to the oligosaccharide portion of its cell surface receptor, ganglioside GM1","volume":"28","author":"A Schon","year":"1989","journal-title":"Biochemistry"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"21604","DOI":"10.1074\/jbc.271.35.21604","article-title":"Intracellular trafficking of cholesterol monitored with a cyclodextrin","volume":"271","author":"EB Neufeld","year":"1996","journal-title":"J Biol Chem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"16541","DOI":"10.1016\/S0021-9258(18)55335-7","article-title":"ATP synthase of yeast mitochondria. Characterization of subunit d and sequence analysis of the structural gene ATP7","volume":"266","author":"N Norais","year":"1991","journal-title":"J Biol Chem"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"8405","DOI":"10.1074\/jbc.M112.425769","article-title":"Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast","volume":"288","author":"A Cuesta-Marban","year":"2013","journal-title":"J Biol Chem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"240ra75","DOI":"10.1126\/scitranslmed.3007646","article-title":"Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy","volume":"6","author":"JP Weichert","year":"2014","journal-title":"Sci Transl Med"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.4049\/jimmunol.0713598","article-title":"IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice","volume":"182","author":"S Lopez Kostka","year":"2009","journal-title":"J Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e91970","DOI":"10.1371\/journal.pone.0091970","article-title":"The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response","volume":"9","author":"P Abramowski","year":"2014","journal-title":"PLoS One"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2014.07.007","article-title":"Immunomodulatory effects of the ether phospholipid edelfosine in experimental autoimmune encephalomyelitis","volume":"274","author":"P Abramowski","year":"2014","journal-title":"J Neuroimmunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"e0003893","DOI":"10.1371\/journal.pntd.0003893","article-title":"Inhibition of granulomatous inflammation and prophylactic treatment of schistosomiasis with a combination of edelfosine and praziquantel","volume":"9","author":"E Yepes","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bjp.0702606","article-title":"Induction of apoptosis in human mitogen-activated peripheral blood T- lymphocytes by the ether phospholipid ET-18-OCH<sub>3<\/sub>: involvement of the Fas receptor\/ligand system","volume":"127","author":"C Cabaner","year":"1999","journal-title":"Br J Pharmacol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"e31342","DOI":"10.1371\/journal.pone.0031342","article-title":"Exogenous ether lipids predominantly target mitochondria","volume":"7","author":"L Kuerschner","year":"2012","journal-title":"PLoS ONE"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10495-010-0460-5","article-title":"Potential involvement of F<sub>0<\/sub>F<sub>1<\/sub>-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines: a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein","volume":"15","author":"L Veenman","year":"2010","journal-title":"Apoptosis"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1038\/sj.onc.1206053","article-title":"Oligomycin, inhibitor of the F<sub>0<\/sub> part of H<sup>+<\/sup>-ATP-synthase, suppresses the TNF-induced apoptosis","volume":"21","author":"LA Shchepina","year":"2002","journal-title":"Oncogene"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"11643","DOI":"10.1021\/jp802165n","article-title":"Edelfosine is incorporated into rafts and alters their organization","volume":"112","author":"A Ausili","year":"2008","journal-title":"J Phys Chem B"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1021\/jp401407d","article-title":"Edelfosine and miltefosine effects on lipid raft properties: membrane biophysics in cell death by antitumor lipids","volume":"117","author":"BM Castro","year":"2013","journal-title":"J Phys Chem B"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1016\/S0021-9258(19)50676-7","article-title":"Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations","volume":"267","author":"P Bernardi","year":"1992","journal-title":"J Biol Chem"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1097-2765(00)80033-7","article-title":"The Mitochondrial F<sub>0<\/sub>F<sub>1<\/sub>-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells","volume":"1","author":"S Matsuyama","year":"1998","journal-title":"Mol Cell"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/jac\/dkp321","article-title":"Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant <italic>Leishmania donovani<\/italic> promastigotes","volume":"64","author":"M Saint-Pierre-Chazalet","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.4049\/jimmunol.0803476","article-title":"Macrophage NADPH oxidase flavocytochrome B localizes to the plasma membrane and Rab11-positive recycling endosomes","volume":"182","author":"AJ Casbon","year":"2009","journal-title":"J Immunol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"10368","DOI":"10.1158\/0008-5472.CAN-07-0278","article-title":"Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells","volume":"67","author":"T Nieto-Miguel","year":"2007","journal-title":"Cancer Res"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1084\/jem.180.1.273","article-title":"A novel ligand in lymphocyte-mediated cytotoxicity: expression of the beta subunit of H<sup>+<\/sup> transporting ATP synthase on the surface of tumor cell lines","volume":"180","author":"B Das","year":"1994","journal-title":"J Exp Med"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1002\/pmic.200400952","article-title":"Lipid raft proteome reveals ATP synthase complex in the cell surface","volume":"4","author":"TJ Bae","year":"2004","journal-title":"Proteomics"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/abbs\/gmq063","article-title":"Mitochondrial F<sub>1<\/sub>F<sub>o<\/sub>-ATP synthase translocates to cell surface in hepatocytes and has high activity in tumor-like acidic and hypoxic environment","volume":"42","author":"Z Ma","year":"2010","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1586\/epr.10.87","article-title":"Lipid raft proteome reveals that oxidative phosphorylation system is associated with the plasma membrane","volume":"7","author":"BW Kim","year":"2010","journal-title":"Expert Rev Proteomics"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"C1139","DOI":"10.1152\/ajpcell.00199.2013","article-title":"Cell surface F<sub>1<\/sub>\/F<sub>O<\/sub> ATP synthase contributes to interstitial flow-mediated development of the acidic microenvironment in tumor tissues","volume":"305","author":"Y Kawai","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/jcb.24511","article-title":"The mechanism underlying the effects of the cell surface ATP synthase on the regulation of intracellular acidification during acidosis","volume":"114","author":"WJ Wang","year":"2013","journal-title":"J Cell Biochem"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1210\/me.2015-1324","article-title":"The F<sub>0<\/sub>F<sub>1<\/sub> ATP synthase complex localizes to membrane rafts in gonadotrope cells","volume":"30","author":"K Allen-Worthington","year":"2016","journal-title":"Mol Endocrinol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"S Sundar","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"S Rijal","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"e0004093","DOI":"10.1371\/journal.pntd.0004093","article-title":"Decline in clinical efficacy of oral miltefosine in treatment of post kala-azar dermal leishmaniasis (PKDL) in India","volume":"9","author":"V Ramesh","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"e0005641","DOI":"10.1371\/journal.pntd.0005641","article-title":"Increased miltefosine tolerance in clinical isolates of <italic>Leishmania donovani<\/italic> is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress","volume":"11","author":"DK Deep","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","article-title":"<italic>Leishmania donovani<\/italic> resistance to miltefosine involves a defective inward translocation of the drug","volume":"47","author":"FJ Perez-Victoria","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2006.04.001","article-title":"Mechanisms of experimental resistance of <italic>Leishmania<\/italic> to miltefosine: Implications for clinical use","volume":"9","author":"FJ Perez-Victoria","year":"2006","journal-title":"Drug Resist Updat"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00436-014-3755-6","article-title":"Comparative transcript expression analysis of miltefosine-sensitive and miltefosine-resistant <italic>Leishmania donovani<\/italic>","volume":"113","author":"A Kulshrestha","year":"2014","journal-title":"Parasitol Res"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0005805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T16:33:18Z","timestamp":1659371598000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0005805"}},"subtitle":[],"editor":[{"given":"Syamal","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":88,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0005805","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]}}}